How digital spacial profiling is changing the fight against lung cancer

Lung cancer is the leading cause of cancer death globally, and while immunotherapies and targeted therapies have been transformative, they only work in roughly 1 in 5 patients. We have not been able to reliably predict who will respond, until now. Digital Spatial Profiling allows us to read the tumour microenvironment: the complex ecosystem of immune cells, cancer cells, and supporting structures that ultimately determines whether a treatment succeeds or fails.